We are committed to improving the lives of those affected by Duchenne through accelerating research, improving care and empowering the community. Join us in our mission, help us save the lives of over 300,000 boys worldwide. CureDuchenne is committed to improving the lives of everyone affected by Duchenne muscular dystrophy (DMD) through accelerating research to find the cure, improving care and empowering the Duchenne community. From creating the first Duchenne-specific physical therapy education program and enabling human clinical trials for the first-ever FDA approved drug for these patients, to launching a supplemental newborn screening initiative, we believe in tackling Duchenne from every angle. Duchenne is a 100% fatal genetic disease and the most common form of muscular dystrophy, which affects mostly boys. There are over 300,000 patients worldwide and 15,000 in the US.